Jacobs Jeffrey P
Division of Cardiovascular Surgery, Department of Surgery, Johns Hopkins All Children's Heart Institute, Johns Hopkins All Children's Hospital and Florida Hospital for Children, Saint Petersburg, Tampa, and Orlando, FL; Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2017 Jan;20:43-48. doi: 10.1053/j.pcsu.2016.09.008.
Three basic principles provide the rationale for the Society of Thoracic Surgeons (STS) Congenital Heart Surgery Database (CHSD) public reporting initiative: (1) Variation in congenital and pediatric cardiac surgical outcomes exist. (2) Patients and their families have the right to know the outcomes of the treatments that they will receive. (3). It is our professional responsibility to share this information with them in a format they can understand. The STS CHSD public reporting initiative facilitates the voluntary transparent public reporting of congenital and pediatric cardiac surgical outcomes using the STS CHSD Mortality Risk Model. The STS CHSD Mortality Risk Model is used to calculate risk-adjusted operative mortality and adjusts for the following variables: age, primary procedure, weight (neonates and infants), prior cardiothoracic operations, non-cardiac congenital anatomic abnormalities, chromosomal abnormalities or syndromes, prematurity (neonates and infants), and preoperative factors (including preoperative/preprocedural mechanical circulatory support [intraaortic balloon pump, ventricular assist device, extracorporeal membrane oxygenation, or cardiopulmonary support], shock [persistent at time of surgery], mechanical ventilation to treat cardiorespiratory failure, renal failure requiring dialysis and/or renal dysfunction, preoperative neurological deficit, and other preoperative factors). Operative mortality is defined in all STS databases as (1) all deaths, regardless of cause, occurring during the hospitalization in which the operation was performed, even if after 30 days (including patients transferred to other acute care facilities); and (2) all deaths, regardless of cause, occurring after discharge from the hospital, but before the end of the 30 postoperative day. The STS CHSD Mortality Risk Model has good model fit and discrimination with an overall C statistics of 0.875 and 0.858 in the development sample and the validation sample, respectively. These C statistics are the highest C statistics ever seen in a pediatric cardiac surgical risk model. Therefore, the STS CHSD Mortality Risk Model provides excellent adjustment for case mix and should mitigate against risk aversive behavior. The STS CHSD Mortality Risk Model is the best available model to date for measuring outcomes after pediatric cardiac surgery. As of March 2016, 60% of participants in STS CHSD have agreed to publicly report their outcomes through the STS Public Reporting Online website (http://www.sts.org/quality-research-patient-safety/sts-public-reporting-online). Although several opportunities exist to improve our risk models, the current STS CHSD public reporting initiative provides the tools to report publicly, and with meaning and accuracy, the outcomes of congenital and pediatric cardiac surgery.
胸外科医师协会(STS)先天性心脏病手术数据库(CHSD)公开报告计划基于三项基本原则:(1)先天性和小儿心脏手术结果存在差异。(2)患者及其家属有权了解他们即将接受的治疗结果。(3)我们有专业责任以他们能够理解的形式与他们分享这些信息。STS CHSD公开报告计划利用STS CHSD死亡率风险模型,促进先天性和小儿心脏手术结果的自愿透明公开报告。STS CHSD死亡率风险模型用于计算风险调整后的手术死亡率,并针对以下变量进行调整:年龄、主要手术、体重(新生儿和婴儿)、既往心胸手术、非心脏先天性解剖异常、染色体异常或综合征、早产(新生儿和婴儿)以及术前因素(包括术前/术前机械循环支持[主动脉内球囊泵、心室辅助装置、体外膜肺氧合或心肺支持]、休克[手术时持续存在]、用于治疗心肺衰竭的机械通气、需要透析和/或肾功能不全的肾衰竭、术前神经功能缺损以及其他术前因素)。在所有STS数据库中,手术死亡率定义为:(1)在进行手术的住院期间发生的所有死亡,无论原因如何,即使在30天后(包括转至其他急性护理机构的患者);(2)出院后但在术后30天结束前发生的所有死亡,无论原因如何。STS CHSD死亡率风险模型具有良好的模型拟合度和区分度,在开发样本和验证样本中的总体C统计量分别为0.875和0.858。这些C统计量是小儿心脏手术风险模型中见过的最高C统计量。因此,STS CHSD死亡率风险模型对病例组合提供了出色的调整,应能减轻规避风险行为。STS CHSD死亡率风险模型是迄今为止用于衡量小儿心脏手术后结果的最佳可用模型。截至2016年3月,STS CHSD中60%的参与者已同意通过STS公开报告在线网站(http://www.sts.org/quality-research-patient-safety/sts-public-reporting-online)公开报告他们的结果。尽管有几个机会可以改进我们的风险模型,但当前的STS CHSD公开报告计划提供了公开报告先天性和小儿心脏手术结果的工具,且报告具有意义和准确性。